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Signs	and	Symptoms	
Pulmonary	Embolism	
Kira	Robison,	RN	
Introduc6on	 Pathophysiological	Process	
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Facts/Sta6s6cs	Acute	PE	caused	by	thrombo-emboli	may	be	spontaneous	and	often	originates	in	the	deep	venous	system	of	the	lower	extremities,	upper	extremities,	right	side	of	the	heart,	or	pelvis	(Morici,	2014).	There	are	several	factors	that	can	increase	a	patient’s	susceptibility	to	thrombus	formation.	Virchow	triad	(stasis,	vascular	wall	injury,	and	hypercoagulability)	can	be	used	to	assess	the	patient’s	risk	of	developing	thrombi	(Morici,	2014).	Stasis	is	often	considered	the	most	prominent	factor,	which,	in	conjunction	with	either	vessel	damage	or	hypercoagulability,	can	lead	to	clot	formation;	stasis	can	present	in	a	variety	of	settings,	including	immobilization,	chronic	venous	insufgiciency,	paresis	secondary	to	stroke	or	other	causes,	and	varicose	veins	(Morici,	2014).		Once	deep	vein	thrombosis	develops,	clots	may	dislodge	and	travel	through	the	venous	system	and	the	right	side	of	the	heart	to	lodge	in	the	pulmonary	arteries,	where	they	partially	or	completely	occlude	one	or	more	vessels	(Tapson,	2018).	The	outcome	depends	on	the	size	and	number	of	emboli,	the	underlying	condition	of	the	lungs,	how	well	the	right	ventricle	is	functioning,	and	the	ability	of	the	patients	body	to	dissolve	the	clot(s).		Small	emboli	may	have	no	acute	physiologic	effects	and	may	begin	to	lyse	immediately	and	resolve	within	hours	or	days.	Larger	emboli	can	cause	a	reglex	increase	in	ventilation	(tachypnea),	hypoxemia	due	to	ventilation/perfusion	(V/Q)	mismatch,	and	low	mixed	venous	oxygen	content	as	a	result	of	low	cardiac	output,	atelectasis	due	to	alveolar	hypocapnia	and	abnormalities	in	surfactant,	and	an	increase	in	pulmonary	vascular	resistance	caused	by	mechanical	obstruction	and	vasoconstriction	(Tapson,	2018).	When	large	emboli	occlude	major	pulmonary	arteries,	or	when	many	small	emboli	occlude	>	50%	of	the	more	distal	vessels,	RV	pressure	increases,	which	may	lead	to	acute	RV	failure,	shock,	or	sudden	death.	The	risk	of	death	depends	on	the	degree	and	rate	of	rise	of	right-sided	pressures	and	on	the	patient’s	underlying	cardiopulmonary	status	(Tapson,	2018).	
•  Genetic	and	acquired	tendencies		
•  Pregnancy;	use	of	birth	control	pills	or	hormone	therapy	
•  Obesity	
•  Smoking	
•  Cancer	
•  Medical	illnesses	including	hear	disease,	lung	disease,	and	kidney	disease	
•  Older	age	
•  Recent	surgery,	trauma,	hospitalization,	or	prolonged	bed	rest	
	OBerbein	University,	Westerville,	Ohio 		
•  Acute	PE	is	a	common	and	potentially	devastating	medical	condition.	
•  In	an	acute	or	ambulatory	care	setting,	providers	will	likely	be	faced	with	patients	who	present	with	signs	and	symptoms	indicative	of	PE.		
•  Clinical	suspicion	and	congirmatory	diagnosis	are	essential	because	in	most	patients	who	die	from	acute	PE,	PE	is	not	even	suspected.	
•  Due	to	the	poor	specigicity	of	these	presenting	cases,	clinicians	must	be	vigilant	about	suspecting	PE	in	patients	at	an	increased	risk.		
•  Prompt	triage,	imaging,	and	treatment	can	improve	morbidity	and	mortality	signigicantly.		
•  Discovering	the	underlying	pathology	can	assist	providers	in	determining	the	length	of	therapy	and	need	for	continued	treatment	and	prevention.	
•  Because	anticoagulation	improves	survival,	patients	with	PE	should	be	considered	for	thrombolytic	therapy	or	embolectomy.	
•  Recent	pharmaceutical	and	technological	advances	have	added	to	the	treatments	available	for	PE	and	will	continue	to	evolve	as	scientigic	research	continues,	with	a	goal	of	further	improving	identigication,	diagnosis,	and	treatment	of	acute	PE.	
Conclusion	
•  Presentation 
Harry is an 81 year-old man who presents to your ED with a 3 day history of breathlessness. He 
reports coughing up fresh blood and a sharp pain on the left side of his chest on taking a deep 
breath.  
 
•  Question 
You believe Harry has symptoms of a suspected PE. What would you do next? 
 
•  Answer: 
Carry out an assessment of his general medical history, a physical examination and a chest x-
ray to exclude other causes. On examination his  vitals are RR 20 breaths per minute, BP 
145/90 mmHg, HR 72 beats per min, Temp 37.5c, SpO2 92% on RA. Upon auscultation of his 
lungs you hear crackles at the left base. Chest x-ray shows a small left-sided pleural effusion. 
Upon further questioning you find out that Harry has been in bed for the part 4 days because he 
felt unwell. 
 
•  Question 
You still suspect pulmonary embolism. What would you do next? 
 
•  Answer 
Offer Harry a D-dimer test. 
 
•  Question 
Harry’s D-dimer is positive. What would you do next? 
 
•  Answer 
Offer an immediate CPTA. On this occasion CTPA is available for Harry immediately. The 
consultant in charge assesses Harry and deems him stable for transfer for CTPA. The CT 
department agree to accept him for CTPA and he is transferred with medical escort. 
 
•  Question 
Harry’s CTPA is positive for PE and he remains hemodynamically unstable. What would you do 
next? 
 
•  Answer 
Diagnose PE and treat as soon as possible. Because of Harry’s hemodynamic instability start 
unfractionated heparin and consider offering systematic thrombolytic therapy. In considering 
systematic thrombolytic therapy, expert clinical opinion advises provision of adequate 
monitoring facilities. Harry agrees to being treated with systemic thrombolytic therapy and 
appropriate facilities are made immediately available to safely administer and monitor 
systematic thrombolytic therapy. Following the acute management phase Harry is stabilized and 
continues on UFH until the international normalized ratio (INR) (adjusted by a VKA) is 2 or 
above for at least 24 hours. 
("Venous	Thromboembolic	Diseases,"	2012)	
 								
Case	Study	 As	an	advanced	practice	nurse,	it	is	important	to	know	the	signs	and	symptoms	of	pulmonary	embolism	(PE).	Due	to	the	fact	that	the	signs	and	symptoms	associated	with	PE	can	be	nonspecigic,	the	condition	can	be	a	diagnostic	challenge.	Often	a	patient	may	present	atypically	or	have	none	of	the	preceding	symptoms;	because	of	the	risk	of	sudden	death	from	acute	PE,	clinicians	should	have	a	heightened	awareness	of	PE	when	assessing	patients	(Morici,	2014).		Being	proactive	and	preventing	a	DVT/PE	from	ever	developing	is	a	key	responsibility	of	clinicians.	Bedbound	patients	and	patients	undergoing	surgical,	especially	orthopedic,	procedures	can	be	identigied	as	“high	risk”	before	a	thrombus	ever	forms.	Preventive	measures	include	low-dose	unfractionated	heparin,	low	molecular	weight	heparin,	warfarin,	fondaparinux,	oral	anticoagulants	(rivaroxaban,	apixaban,	dabigatran),	compression	devices,	and	elastic	compression	stockings	(Tapson,	2018).	Choice	of	drug	or	device	depends	on	various	factors,	including	the	patient	population,	the	perceived	risk,	contraindications,	relative	costs,	and	ease	of	use.		If	a	PE	develops	in	the	acute	setting,	the	initial	treatment	should	be	focused	on	stabilizing	the	patient.	Provide	supplemental	oxygen	to	ensure	adequate	oxygenation,	and	monitor	pulse	oximetry	continually,	with	a	reasonable	goal	of	92%.	The	mainstay	therapy	for	PE	is	anticoagulation.	Treatment	options	include	unfractionated	heparin,	fondaparinux,	warfarin,	and	rivaroxaban.	The	American	College	of	Chest	Physicians	(ACCP)	suggests	LMWH	as	the	initial	anticoagulant;	however,	treatment	should	be	individualized	based	on	the	patient's	characteristics	and	comorbidities	(Morici,	2014).		
Nursing	Implica6ons	
•  Shortness	of	breath	(dyspnea)		
•  Chest	discomfort	
•  Coughing	up	blood	(hemoptysis)		
•  Palpitations	
•  Dizziness	and	fainting	
•  Leg	swelling	and	discomfort	
•  Increased	respiratory	rate	(tachypnea)	
•  Shortness	of	breath	when	lying	glat	(orthopnea)	
•  Increased	heart	rate	(tachycardia)	
•  Decreased	breath	sounds	
•  Jugular	Venous	Distention	(JVD)	
Deep	vein	thrombosis	(DVT)	and	Pulmonary	Embolism	(PE)	are	often	under	diagnosed,	but	are	serious	medical	conditions	that	can	be	prevented.	Specigically,		“a	pulmonary	embolism	is	a	blockage	in	the	pulmonary	artery,	which	supplies	the	blood	to	the	lungs.	It	is	one	of	the	most	common	cardiovascular	diseases	in	the	United	States”(Crosta,	2018).	Due	to	this	very	reason,	the	pathophysiological	topic	of	acute	pulmonary	embolism	was	chosen	to	be	researched	so	that	a	more	thorough	understanding	of	the	topic	could	be	reached.			Acute	pulmonary	embolism	is	a	life-threatening	diagnosis	that	can	present	with	a	multitude	of	nonspecigic	symptoms	and	can	quickly	become	a	life-threatening	diagnosis.	Clinicians	must	approach	suspected	cases	of	PE	with	a	heightened	awareness	and	follow	evidence-based	recommendations	for	the	diagnosis	and	treatment	of	acute	PE	(Morici,	2014).	Pulmonary	embolism	is	among	the	most	treatable	and	preventable	causes	of	death	in	the	United	States	(Minges	et	al.,	2015).			There	are	many	risk	factors	such	as	genetics,	obesity,	birth	control,	pregnancy,	smoking,	recent	surgeries,	prolonged	bed	rest	and	more	that	will	increase	an	individuals	chances	of	developing	a	DVT/PE.	When	a	patient	presents	with	any	signs	and	symptoms	of	a	possible	PE,	such	as	shortness	of	breath,	chest	discomfort,	hemoptysis,	leg	swelling/discomfort,	etc.	it	is	the	clinicians	responsibility	to	take	the	proper	steps	in	diagnosing	and	treating	the	possible	pulmonary	embolism.	There	are	many	aspects	of	a	patients	care	that	must	be	considered	by	the	clinician	when	taking	care	of	a	patient	with	a	PE.	The	articles	used	throughout	this	presentation	will	help	to	provide	additional	resources	and	education	to	those	individuals	looking	to	increase	their	knowledge	base	in	regards	to	caring	for	a	patient	with	a	pulmonary	embolism.											
•  The	risk	of	PE	increases	with	age	
•  The	risk	of	PE	is	high	for	individuals	who	have	had	a	blood	clot	in	the	leg/arm	
•  In	rare	cases,	a	PE	can	be	caused	by	amniotic	gluid	
•  In	about	25%	of	people	who	experience	a	PE,	the	girst	“symptom”	is	sudden	death	
•  10%	to	30%	of	people	affected	by	DVT/PE	will	die	within	one	month	of	diagnosis	
•  One-third	(about	33%)	of	people	with	DVT/PE	will	die	within	one	month	of	diagnosis	
•  Acute	PE’s	affect	300,000	to	600,000	people	in	the	United	States	annually	("Quick	Facts,"	n.d.)	National	Blood	Clot	Alliance		
(Merrigan, Piazza, & Lynm, 2013)	How	Pulmonary	Embolism	occurs	
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